INTRODUCTION
Interstrand cross-links (ICLs) inhibit transcription and replication. Their considerable cytotoxicity has been ascribed primarily to their blocking of replication forks, and it is this phenomenon that is believed to be responsible for the success of ICL-inducing agents such as cisplatin and mitomycin-C (MMC) in cancer chemotherapy (1) . ICL processing is complex, inasmuch as it involves proteins from several distinct pathways of DNA metabolism. In higher organisms, it is orchestrated by the Fanconi anemia (FA) pathway (2, 3) . Collision of replication forks with ICLs activates the ATR kinase, which in turn licenses the FANCL ubiquitin ligase subunit of the FA core complex (composed of FANCA, B, C, E, F, G, L and M proteins) to modify the FANCD2-FANCI heterodimer (2, (4) (5) (6) . The mono-ubiquitylated FANCD2-FANCI complex is then targeted to chromatin (7, 8) , where it recruits downstream components of the repairosome including the structure-specific nuclease FAN1 (9-12). However, ICL processing requires also other enzymes, such as the nucleases MUS81-EME1 and XPF-ERCC1 and it is currently not known how these are recruited to sites of damage in ICL repair.
The structure-specific endonucleases XPF-ERCC1 and MUS81-EME1, which are implicated in ICL repair and in the resolution of homologous recombination (HR) intermediates (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) , interact with SLX4. The latter polypeptide interacts also with SLX1 both in yeast (23, 24) and in mammalian cells (21, 22, 25, 26 ) and the resulting complex displays 5'-flap endonuclease and Holliday junction resolvase activities. Based on this evidence, SLX4 has been assigned the role of a docking platform for structure-specific endonucleases and its pivotal role in regulating their activities is underscored by the finding that SLX4 downregulation sensitizes human cells to a wide variety of DNA-damaging agents (21, 22, 25, 26). However, although SLX4 has been implicated also in ICL repair, its role in this process, as well as its possible link to the FA pathway remains to be elucidated.
In this study, we set out to characterize the biological role of SLX4 by conditionally disrupting the SLX4 gene in chicken DT40 cells (27) . We now report that loss of SLX4 induces cell death associated with extensive chromosome aberrations, which shows that SLX4 plays a key role in the repair of spontaneous DNA damage.
Many proteins interacting with ubiquitylated polypeptides contain so-called Role of SLX4 in ICL repair
Yamamoto et al. 4 ubiquitin-binding zinc finger (UBZ) domains (28). Because ubiquitylation plays an important role in ICL repair, we asked whether the UBZ domain of SLX4 is required for DNA damage processing. We show here that this domain is essential for the recruitment of SLX4 to sites of DNA damage upon exposure of cells to cross-linking agents, and that this recruitment is dependent on FANCD2 ubiquitylation. Consistently, the UBZ domain of SLX4 is required for interaction with mono-ubiquitylated FANCD2.
Our data thus indicate that SLX4 involvement in ICL repair is controlled by the FA pathway.
RESULTS

SLX4 is essential for cell proliferation.
To disrupt the SLX4 gene, we used gene-targeting constructs designed to delete the five exons that encode residues 124 to 518 of the protein (Fig. S1A) . However, we failed to generate SLX4 -/-cells, which suggested that SLX4 is essential for DT40 cell survival. We therefore first disrupted one SLX4 allele and stably transfected the SLX4 +/-cells with constructs expressing the tTA repressor, and the chicken SLX4 transgene under the control of doxycycline-repressible promoter (tetSLX4) (29). We then disrupted the second SLX4 allele and confirmed the successful disruption by Southern blotting (Fig. S1B) . RT-PCR analysis showed that the SLX4 -/-tetSLX4 cells expressed SLX4 mRNA, and that this transcript was undetectable in doxycycline-treated cells after 72 h (Fig. 1A) . The SLX4 -/-tet SLX4 cells proliferated slightly slower than wild type (WT) cells, possibly due to nonphysiological levels of expression of SLX4 (Fig. 1B) . 24 h after the addition of doxycycline, the SLX4 transcript was barely-detectable ( Fig. 1A) , and the proliferation of the SLX4 -/-tetSLX4 cells slowed down considerably (Fig. 1B) . After 48 h doxycycline treatment, the SLX4 -/-tetSLX4 cells accumulated in the G 2 phase of the cell cycle, with many cells dying (Fig. 1C) , indicating that SLX4 is essential for cell proliferation at least in DT40 cells. This result is marked contrast with the viability of SLX4 knockout mice (30). This difference might possibly be attributable to the absence of the MUS81 gene in the chicken genome.
Chromosome analysis of mitotic cells showed an increased number of spontaneous chromosomal aberrations, as seen in HR-deficient cells (Table S1 ). The above-described phenotypic traits were observed in two independent SLX4 -/-tetSLX4 clones, which argues against clone-specific effects and demonstrates that SLX4 plays a pivotal role in the repair of spontaneous DNA damage (Fig. 1D , Table S1 ). Following treatment with DNA damaging agents, FANCD2 and other repair proteins accumulate in subnuclear foci (7-9). In order to find out whether SLX4 also Table S2 ) faithfully reflects the greater sensitivity of the former cells to MMC ( Fig. 4A and Fig. S7 ). Thus, SLX4 and the FA pathway appear to contribute to ICL repair also independently of each other.
SLX4 is required for HR
FANCC -/SLX4 -/-tetSLX4 cells (Fig. 4B,
DISCUSSION
In this study, we demonstrate that SLX4 is required for HR-dependent DSB repair, possibly for resolution of recombination intermediates, at least as implied by the substrate specificity of its complex with SLX1 (21, 26). We also show that SLX4 is recruited to sites of DNA damage by mono-ubiquitylated FANCD2 and that this recruitment requires the SLX4 UBZ domain. Thus, ubiquitylation of FANCD2 by the FA core complex has at least two functions: the recently-described recruitment of FAN1 (9-12) and the recruitment of SLX4 documented in the present study.
The following lines of evidence support the conclusion that SLX4 participates (Fig. 2). (ii) SLX4 recruitment to DNA-damage sites was dependent on FANCD2 mono-ubiquitylation (Fig. 3) . (iii) This recruitment required the ubiquitin-binding domain of SLX4 (Fig. 3) . (iv) SLX4 interaction with ubiquitylated FANCD2 required the SLX4 UBZ domain (Fig. 3) UBZ domain would abolish also the FA-independent interactions and the pattern of chromosomal aberrations would alter yet again (Fig. S8) .
The role of SLX4 in DNA repair is believed to be that of a docking platform 
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